1-8 of 8
Alexander D. Kulagin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Giuliano Filippini Velazquez, Myriam Labopin, Johanna Tischer, Emanuele Angelucci, Alexander D. Kulagin, Piero Galieni, Arancha Bermúdez, Claude-Eric Bulabois, Nicolaus Kröger, José Luis Díez-Martin, Arnon Nagler, Christoph Schmid, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 7744–7746.
https://doi.org/10.1182/blood-2022-160229
Published: 2022
Journal Articles

Artificial Intelligence Methods to Estimate Overall Mortality and Non-Relapse Mortality Following Allogeneic Hematopoietic Cell Transplantation in the Modern Era: An EBMT Transplant Complications Working Party Study

Blanca Rius Sansalvador, Alberto Mussetti, Victor Moreno, Christophe Peczynski, Emmanuelle Polge, Nicolaus Kröger, Didier Blaise, Régis Peffault de Latour, Alexander D. Kulagin, Ashrafsadat Mousavi, Matthias Stelljes, Rose-Marie Hamladji, Martin Bornhäuser, Urpu Salmenniemi, Henrik Sengeloev, Edouard Forcade, Uwe Platzbecker, Péter Reményi, Emanuele Angelucci, Patrice Chevallier, Ibrahim Yakoub-Agha, Charles Craddock, Fabio Ciceri, Thomas Schroeder, Mahmoud Aljurf, Ivan Moiseev, Olaf Penack, Helene Schoemans, Mohamad Mohty, Bertram Glass, Anna Sureda, Grzegorz W Basak, Zinaida Peric
Journal: Blood
Blood (2022) 140 (Supplement 1): 7734–7737.
https://doi.org/10.1182/blood-2022-168601
Published: 2022
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr -Mutated Myelofibrosis

Juan Carlos Hernandez Boluda, Dirk-Jan Eikema, Nadia Erazo, Nicolaus Kröger, Marie Robin, Moniek de Witte, Jürgen Finke, Alessandro Rambaldi, Annoek E.C. Broers, Ludek Raida, Nicolaas Schaap, Patrizia Chiusolo, Mareike Verbeek, Goda Choi, Kazimierz Halaburda, Alexander D. Kulagin, Helene Labussiere-Wallet, Tobias Gedde-Dahl, Werner Rabitsch, Kavita Raj, Joanna Drozd-Sokolowska, Nicola Polverelli, Tomasz Czerw, Ibrahim Yakoub-Agha, Donal P. McLornan
Journal: Blood
Blood (2022) 140 (Supplement 1): 10608–10610.
https://doi.org/10.1182/blood-2022-163048
Published: 2022
Journal Articles

Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, Alexander D. Kulagin, Andrea Velardi, Jaime Sanz, Hélène Labussière-Wallet, Victoria Potter, Jurgen Kuball, Simona Sica, Elena N. Parovichnikova, Wolfgang Bethge, Xavier Leleu, Uwe Platzbecker, Friedrich Stölzel, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 7578–7579.
https://doi.org/10.1182/blood-2022-156231
Published: 2022
Journal Articles

Invasive Aspergillosis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Large Cohort Single-Center Study

Yuliya A. Rogacheva, Vladislav V. Markelov, Marina O. Popova, Alisa G. Volkova, Ilya Y. Nikolaev, Olga N. Pinegina, Svetlana M. Ignatyeva, Tatiyana S. Bogomolova, Sergey N. Bondarenko, Nikolay N. Klimko, Alexander D. Kulagin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1801.
https://doi.org/10.1182/blood-2021-153762
Published: 2021
Journal Articles

Predictive Model and Factors of Relapse after Allogeneic Stem Cell Transplantation in Adults with Ph-Positive Acute Lymphoblastic Leukemia

Kseniia S. Afanaseva, Evgeny A. Bakin, Olga V. Pirogova, Elena V. Morozova, Ildar M. Barkhatov, Anna G. Smirnova, Sergey N. Bondarenko, Ivan S. Moiseev, Alexander D. Kulagin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3934.
https://doi.org/10.1182/blood-2021-153763
Published: 2021
Journal Articles

Transfusion Requirements in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria with or without a History of Bone Marrow Disorder Receiving Ravulizumab and Eculizumab: Results from a Phase 3 Non-Inferiority Study Extension

Antonio Risitano, Jun-Ho Jang, MD, Lee Gyeong-Won, Wanchai Wanachiwanawin, Hubert Schrezenmeier, Yuji Yonemura, MDPhD, Talha Munir, MBBS, Rodrigo Pavani, Jimmy Wang, Alexander D. Kulagin, MD PhD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Flore Sicre de Fontbrune, Alexander Röth, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–33.
https://doi.org/10.1182/blood-2020-140418
Published: 2020
Journal Articles

Efficacy and Safety of Ravulizumab in Older Patients Aged >65 Years with Paroxysmal Nocturnal Hemoglobinuria in the 301 and 302 Phase 3 Extension Studies

Regis Peffault De Latour, MD PhD, Jeffrey Szer, MBBS, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Jin Seok Kim, MD PhD, Caroline I. Piatek, MD, Alexander D. Kulagin, MD PhD, Anita Hill, Jimmy Wang, Ji Yu, Masayo Ogawa, MD FAAP, Hubert Schrezenmeier, Jong Wook Lee, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-140777
Published: 2020